Literature DB >> 22237891

Evaluation of gamma interferon (IFN-γ)-induced protein 10 responses for detection of cattle infected with Mycobacterium bovis: comparisons to IFN-γ responses.

W R Waters1, T C Thacker, B J Nonnecke, M V Palmer, I Schiller, B Oesch, H M Vordermeier, E Silva, D M Estes.   

Abstract

Gamma interferon (IFN-γ)-induced protein 10 (IP-10) has recently shown promise as a diagnostic biomarker of Mycobacterium tuberculosis infection of humans. The aim of the current study was to compare IP-10 and IFN-γ responses upon Mycobacterium bovis infection in cattle by using archived samples from two aerosol inoculation studies. In the first study (10(4) CFU M. bovis by aerosol, n = 7), M. bovis purified protein derivative (PPDb)-specific IP-10 and IFN-γ gene expression was detected as early as 29 days after challenge. PPDb-specific IP-10 and IFN-γ mRNA responses followed a similar pattern of expression over the course of this study and were highly correlated (r = 0.87). In the second study (10(5) CFU M. bovis by aerosol, n = 5), IP-10 and IFN-γ (protein) responses to mycobacterial antigens were compared following challenge. IFN-γ responses to mycobacterial antigens were detected at 29 days after challenge and were sustained during the remainder of the study. IFN-γ responses to mycobacterial antigens exceeded corresponding responses in nonstimulated cultures. IP-10 responses to mycobacterial antigens exceeded preinfection responses at 7, 29, and 63 days after challenge. In contrast to IFN-γ responses, IP-10 responses to mycobacterial antigens generally did not exceed the respective responses in nonstimulated cultures. IP-10 responses to medium alone and to mycobacterial antigens followed a similar pattern of response. Correlations between IP-10 and IFN-γ (protein) responses were modest (r ≈ 0.50 to 0.65). Taken together, these findings do not support the use of IP-10 protein as a biomarker for bovine tuberculosis using the current testing protocol and reagents; however, mRNA-based assays may be considered for further analysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237891      PMCID: PMC3294610          DOI: 10.1128/CVI.05657-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  34 in total

1.  Simultaneous measurement of antigen-stimulated interleukin-1 beta and gamma interferon production enhances test sensitivity for the detection of Mycobacterium bovis infection in cattle.

Authors:  Gareth J Jones; Chris Pirson; R Glyn Hewinson; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients.

Authors:  M G Aabye; M Ruhwald; G Praygod; K Jeremiah; M Faurholt-Jepsen; D Faurholt-Jepsen; N Range; H Friis; J Changalucha; A B Andersen; P Ravn
Journal:  Eur Respir J       Date:  2010-12       Impact factor: 16.671

3.  Increased IL-17 expression is associated with pathology in a bovine model of tuberculosis.

Authors:  Federico Carlos Blanco; María Verónica Bianco; Virginia Meikle; Sergio Garbaccio; Lucas Vagnoni; Marina Forrellad; Laura Inés Klepp; Angel Adrián Cataldi; Fabiana Bigi
Journal:  Tuberculosis (Edinb)       Date:  2010-12-24       Impact factor: 3.131

4.  Aerosol delivery of virulent Mycobacterium bovis to cattle.

Authors:  M V Palmer; W Ray Waters; D L Whipple
Journal:  Tuberculosis (Edinb)       Date:  2002       Impact factor: 3.131

Review 5.  Bovine tuberculosis: a review of current and emerging diagnostic techniques in view of their relevance for disease control and eradication.

Authors:  I Schiller; B Oesch; H M Vordermeier; M V Palmer; B N Harris; K A Orloski; B M Buddle; T C Thacker; K P Lyashchenko; W R Waters
Journal:  Transbound Emerg Dis       Date:  2010-06-18       Impact factor: 5.005

6.  Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis.

Authors:  M Ruhwald; T Bodmer; C Maier; M Jepsen; M B Haaland; J Eugen-Olsen; P Ravn
Journal:  Eur Respir J       Date:  2008-08-06       Impact factor: 16.671

7.  WC1(+) gammadelta T cells indirectly regulate chemokine production during mycobacterium bovis infection in SCID-bo mice.

Authors:  A J Alvarez; J J Endsley; D Werling; D Mark Estes
Journal:  Transbound Emerg Dis       Date:  2009-05-26       Impact factor: 5.005

8.  Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report.

Authors:  Mariane M Stefani; Jackeline G Guerra; Ana Lucia M Sousa; Mauricio B Costa; Maria Leide W Oliveira; Celina T Martelli; David M Scollard
Journal:  BMC Infect Dis       Date:  2009-05-27       Impact factor: 3.090

9.  IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay.

Authors:  Morten Ruhwald; Morten Bjerregaard-Andersen; Paulo Rabna; Jesper Eugen-Olsen; Pernille Ravn
Journal:  BMC Res Notes       Date:  2009-02-04

10.  Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?

Authors:  Elizabeth Whittaker; Andrea Gordon; Beate Kampmann
Journal:  PLoS One       Date:  2008-12-09       Impact factor: 3.240

View more
  11 in total

1.  Milk yield and reproductive performance of Holstein cows testing positive for bovine tuberculosis.

Authors:  Miguel Mellado; Dulce Reséndiz; Angel Mario Martínez; Maria Angeles de Santiago; Francisco Gerardo Véliz; Jose Eduardo García
Journal:  Trop Anim Health Prod       Date:  2015-04-17       Impact factor: 1.559

2.  IP-10 Is a Sensitive Biomarker of Antigen Recognition in Whole-Blood Stimulation Assays Used for the Diagnosis of Mycobacterium bovis Infection in African Buffaloes (Syncerus caffer).

Authors:  Wynand J Goosen; David Cooper; Michele A Miller; Paul D van Helden; Sven D C Parsons
Journal:  Clin Vaccine Immunol       Date:  2015-06-24

3.  Circulating Mycobacterium bovis peptides and host response proteins as biomarkers for unambiguous detection of subclinical infection.

Authors:  Elise A Lamont; Harish K Janagama; Joao Ribeiro-Lima; Lucy Vulchanova; Meetu Seth; My Yang; Kiran Kurmi; W Ray Waters; Tyler Thacker; Srinand Sreevatsan
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

4.  Interleukin-17A as a Biomarker for Bovine Tuberculosis.

Authors:  W Ray Waters; Mayara F Maggioli; Mitchell V Palmer; Tyler C Thacker; Jodi L McGill; H Martin Vordermeier; Linda Berney-Meyer; William R Jacobs; Michelle H Larsen
Journal:  Clin Vaccine Immunol       Date:  2015-12-16

5.  Mannosylated lipoarabinomannan in serum as a biomarker candidate for subclinical bovine tuberculosis.

Authors:  Elise A Lamont; João Ribeiro-Lima; Wade Ray Waters; Tyler Thacker; Srinand Sreevatsan
Journal:  BMC Res Notes       Date:  2014-08-21

6.  Antigen-Specific IP-10 Release Is a Sensitive Biomarker of Mycobacterium bovis Infection in Cattle.

Authors:  Sven D C Parsons; Kevina McGill; Mairead B Doyle; Wynand J Goosen; Paul D van Helden; Eamonn Gormley
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

7.  Limitations of Using IL-17A and IFN-γ-Induced Protein 10 to Detect Bovine Tuberculosis.

Authors:  Ting Xin; Xintao Gao; Hongjun Yang; Pingjun Li; Qianqian Liang; Shaohua Hou; Xiukun Sui; Xiaoyu Guo; Weifeng Yuan; Hongfei Zhu; Jiabo Ding; Hong Jia
Journal:  Front Vet Sci       Date:  2018-03-06

8.  TB Control in Humans and Animals in South Africa: A Perspective on Problems and Successes.

Authors:  Christina Meiring; Paul D van Helden; Wynand J Goosen
Journal:  Front Vet Sci       Date:  2018-11-27

9.  Evaluation of ethanol vortex ELISA for detection of bovine tuberculosis in cattle and deer.

Authors:  Ashutosh Wadhwa; Rachel E Johonson; Keiko Eda; W Ray Waters; Mitchell V Palmer; John P Bannantine; Shigetoshi Eda
Journal:  BMC Vet Res       Date:  2014-07-04       Impact factor: 2.741

10.  Positive Correlation between IP-10 and IFN-γ Levels in Rhesus Monkeys (Macaca mulatta) with Either Naturally Acquired or Experimental Infection of Mycobacterium tuberculosis.

Authors:  Fangui Min; Ruike Wu; Jinchun Pan; Shuwu Huang; Yinzhu Luo; Yu Zhang
Journal:  Biomed Res Int       Date:  2017-04-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.